HPRA Drug Safety Newsletter Edition 88
Download:
hpra-drug-safety-newsletter-edition-88.pdf
245 KB
The latest edition of the HPRA Drug Safety Newsletter (DSN) includes important updates to support the safe and appropriate use of the following medicines:
Granulocyte Colony Stimulating Factors (G-CSFs) - Risk of aortitis
Ocaliva (obeticholic acid) - Risk of serious liver injury in patients with pre-existing moderate or severe hepatic impairment. Reminder of differential dosing recommendations
Clarithromycin - Reminder on cardiovascular safety and risk minimisation advice
Adverse Reactions Reporting - Reminder
« Back